Living with Wilson Ein Projekt von Betroffenen für Betroffene

← Zurück zu allen Antworten

Can Wilson disease neurological symptoms appear after a liver transplant?

Yes — neurological symptoms including dystonia can emerge or persist years after a successful liver transplant, because the transplant corrects copper overflow but cannot reverse pre-existing brain injury.

A liver transplant is genuinely curative for the liver in Wilson disease, and for most people it stops new copper damage in its tracks.1 But “cured” is not quite the right word for what happens to the brain. The transplant corrects the underlying metabolic defect — your new liver handles copper normally — yet it cannot undo injury that the nervous system has already sustained. Symptoms like dystonia, tremor, or speech difficulties can surface months or even years after a successful transplant, not because the disease is still active, but because damaged brain tissue is showing its full consequences on a delayed timeline.2

Why the transplant does not automatically fix the brain

Copper accumulates in Wilson disease over years, often silently, long before symptoms appear.3 By the time a transplant is performed, neurons and their connections may have already suffered oxidative and structural injury. Restoring normal copper metabolism removes the ongoing insult, but it does not repair myelin, restore lost axons, or reverse basal-ganglia scarring. Think of it like fixing a leaking pipe: once the flooding stops, the water damage to the walls still has to be addressed separately — and some of it may never fully reverse.

The brain also has its own timetable. Neurological signs are not always present at the time of transplant and may only become apparent as the nervous system matures, or as compensatory mechanisms that were masking deficits gradually fail. This is why clinicians sometimes see new neurological findings — dystonia, dysarthria, gait changes — in patients who were neurologically intact before or immediately after transplant.4

What the evidence says about neurological outcomes after transplant

Most studies show that transplant stabilises or improves neurological function in the majority of patients with Wilson disease.1 A 24-case series found that roughly two-thirds of patients with pre-transplant neurological symptoms experienced improvement after transplant, while a minority stayed the same and a small number worsened.1 The picture is less clear for patients who were transplanted primarily for liver failure with minimal pre-operative neurological signs: some of these individuals develop neurological problems in the months or years that follow.5

A 2026 case report described exactly this scenario — a patient who developed generalised dystonia five years after a liver transplant for Wilson disease, with no significant neurological symptoms before the operation.5 The authors note that this delayed presentation likely reflects pre-existing, subclinical brain copper deposition that only became clinically apparent after the acute hepatic crisis was resolved.

It is worth knowing that early neurological worsening — in the first weeks to months after starting treatment (whether chelation or transplant) — is a recognised phenomenon in Wilson disease.6 Rapid redistribution of copper can transiently worsen brain symptoms, even when the treatment itself is working. Delayed worsening years later, as in your situation, is a distinct and less well-characterised pattern, but it is real and documented.2

What to do now

First, the reassuring part: the dystonia you are experiencing is not evidence that your transplant failed, and it is not evidence of recurrent Wilson disease in the liver. Your transplanted liver does not carry the ATP7B mutation and handles copper normally. Serum ceruloplasmin and 24-hour urinary copper are likely to be normal, and your specialist can confirm this with straightforward blood and urine tests.7

What you are experiencing almost certainly reflects the brain catching up, in a sense, with the damage done before transplant. The key questions your specialist will want to address:

  • Is this residual, slowly evolving injury, or something new? Brain MRI and a formal movement disorders assessment can help distinguish between these.
  • Can the dystonia be treated symptomatically? Even though the root cause (copper overload) is gone, dystonia itself can often be managed with medications — anticholinergics, muscle relaxants, botulinum toxin injections for focal forms — and sometimes with specialist physiotherapy.8 A movement disorder neurologist, ideally one familiar with Wilson disease, is the right person to design this plan.
  • Is there any reversible component? Some post-transplant neurological changes do continue to improve over one to five years, though the trajectory is highly individual and hard to predict.

Who to talk to and what to bring to the appointment

Bring your pre-transplant records if you can — particularly any neurological imaging done before or just after transplant. This gives your team a baseline to compare against. Ask for:

  1. Repeat brain MRI with comparison to pre-transplant imaging (if available).
  2. A referral to a neurologist experienced in movement disorders or inherited metabolic diseases.
  3. Copper studies (ceruloplasmin, 24-hour urine copper) to confirm the transplanted liver is working correctly — this will provide peace of mind and rule out the rare scenario of technical complications.

If you have not already connected with a Wilson disease specialist centre (rather than a general transplant follow-up clinic), now is a good time to do so. The medications overview page has background on how Wilson disease is managed medically; your neurological situation calls for a parallel track focused on symptomatic treatment, not copper chelation, since your liver is healthy.

The bottom line

A liver transplant stops the Wilson disease process, but the brain’s own recovery takes years and is sometimes incomplete. Delayed or new-onset neurological symptoms after transplant — including dystonia appearing five or more years later — are documented and do not mean the transplant has failed.5 They mean your nervous system needs its own dedicated evaluation and care, separate from the liver side of things. That evaluation exists, and there are real options for managing what you are experiencing.

This page offers patient education only, not personal medical advice. Please discuss any new or changing symptoms after liver transplant with your transplant team and a neurologist who knows your history.

References


  1. Aksoy, Burhanettin, Zeynep Arslan, İnci Ozgur, Hamit Dundar, Ali Çelik, Serpil Bican Demir, Sibel Erer Ozbek, Mahir Kiyici, Suleyman Başarir Ozkan, and Fatih Kaya. “Does Liver Transplant Improve Neurological Symptoms in Wilson Disease? Report of 24 Cases.” Experimental and Clinical Transplantation 20 (2022): 1009–1015. https://doi.org/10.6002/ect.2022.0206. 

  2. Mohr, Isabel, Jan Pfeiffenberger, Svea Eker, and Ulrich Merle. “Neurological Worsening in Wilson Disease – Clinical Classification and Outcome.” Journal of Hepatology 79, no. 2 (2023): 321–328. https://doi.org/10.1016/j.jhep.2023.04.007. 

  3. Czlonkowska, Anna, et al. “Wilson Disease.” Nature Reviews Disease Primers 4 (2018): article 21. https://doi.org/10.1038/s41572-018-0024-5. 

  4. Schilsky, Michael L., Eve A. Roberts, Josie M. Bronstein, et al. “A Multidisciplinary Approach to the Diagnosis and Management of Wilson Disease: 2022 Practice Guidance on Wilson Disease from the American Association for the Study of Liver Diseases.” Hepatology 82 (2022): E41–E90. https://doi.org/10.1002/hep.32801. 

  5. Edwards, Matthew, Brittany Coleman, Marc Feldman, Paul D. Charles, and Danielle Shpiner. “Generalized Dystonia in a Patient With Wilson Disease 5 Years After Liver Transplant: A Case Report.” Tremor and Other Hyperkinetic Movements 16 (2026). https://doi.org/10.5334/tohm.1120. 

  6. Litwin, Tomasz, Anna Członkowska, and Łukasz Smolinski. “Early Neurological Worsening in Wilson Disease: The Need for an Evidence-Based Definition.” Journal of Hepatology 79 (2023): e241–e242. https://doi.org/10.1016/j.jhep.2023.06.009. 

  7. Alkhouri, Naim, Regino Gonzalez-Peralta, and Valentina Medici. “Wilson Disease: A Summary of the Updated AASLD Practice Guidance.” Hepatology Communications 7 (2023). https://doi.org/10.1097/HC9.0000000000000150. 

  8. Hölscher, Stefan, Britta Leinweber, and Harald Hefter. “Evaluation of the Symptomatic Treatment of Residual Neurological Symptoms in Wilson Disease.” European Neurology 64 (2010): 83–87. https://doi.org/10.1159/000316066. 

Dies ist Patientenaufklärung, keine medizinische Beratung. Besprich Entscheidungen zu deiner Behandlung immer mit deinem eigenen medizinischen Team.